ArticleMedChemComm2017
Upconversion fluorescent and X-ray-sensitive bifunctional nanoprobes for assessing the penetrability of inorganic nanoparticles in the digestive system.
Article in MedChemComm, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 3 citations in OpenAlex.
- Bioimaging with Upconversion Nanoparticles.Advanced photonics research · 2022Article
- An optical strategy for detecting hypochloriteRSC advances · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 1 institution in 3 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Nanotechnology is receiving increasing attention due to its fantastic advantages and potential applications in nanofood and nanomedicine. However, the safety of touching manufactured nanoparticles is still uncertain for human beings. Here, we track inorganic nanoparticles in the digestive system of the mouse through upconversion fluorescence and X-ray imaging, and try to demonstrate whether or not the inorganic nanoparticles will penetrate the digestive system to enter the blood system. Lanthanide-doped upconversion nanoparticles, which can convert infrared light to visible light and are simultaneously sensitive to X-rays, were selected as model inorganic nanoparticles. The investigation clarifies that even the ultrathin nanoparticles (∼5 nm) could not penetrate the digestive tract to enter the bloodstream or surrounding tissues, but were gradually excreted out. Our results help assess the safety of inorganic nanoparticles potentially used in nanofood and nanomedicine.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.